Per-Henrik Groop is Professor and Chief Physician (Emeritus) at Department of Nephrology, University of Helsinki and Helsinki University Hospital, Guest Professor at Department of Diabetes, Monash University, and Baker Heart & Diabetes Institute, Melbourne, Australia. His research is focused on the pathogenesis of diabetic complications with special emphasis on diabetic nephropathy. In order to provide a unique set of clinical resources he initiated the large, nationwide FinnDiane Study in 1997. Professor Groop has published 540 peer-reviewed original articles in high-impact journals, 44 reviews and book chapters, as well as 800 abstracts presented at major international meetings.

Keizo Kanasaki, M.D., Ph.D., graduated from the Shiga University of Medical Science in 1996 and completed his doctorate in 2003. From 2005 to 2010, he undertook postdoctoral training and served as an Instructor at Harvard Medical School and BIDMC in the Kalluri Laboratory. After returning to Japan and serving at Kanazawa Medical University, he became Professor of the First Department of Internal Medicine at Shimane University in 2019. He also serves as a Medical School Council member and Deputy Director of the University Hospital. He received the Japan Diabetes Society Lilly Award in 2016.

Dr Amira Howari is a Senior Clinical Optometrist, health advocate, keynote speaker, educator, media commentator and thought leader committed to advancing person-centred healthcare by bridging clinical expertise, lived experience and health-system innovation. Recognised for her leadership in diabetes and eye health, she works across clinical practice, policy, education and strategic healthcare initiatives to improve outcomes for people living with chronic conditions. Dr Howari serves as a Diabetes Australia Ambassador, Board Director of the Primary Care Diabetes Society of Australia (PCDSA), member of the Diabetes and Endocrine Network at the Agency for Clinical Innovation (NSW Health), guest speaker and former Clinical Supervisor at the University of New South Wales, and former NSW/ACT Board Councillor for Optometry Australia. She holds a Bachelor of Optometry (Honours), Graduate Certificate of Ocular Therapeutics and Master of Optometry from the University of New South Wales. Throughout her career, Dr Howari has worked across corporate, independent, pharmaceutical and ophthalmology settings, including senior Professional Affairs and Clinical Professional Affairs roles. She is also the founder of the PEACE Optometry Conference and currently consults with government agencies, not-for-profit organisations and industry partners on the development and implementation of strategic healthcare initiatives, digital health innovation and multidisciplinary models of care. An internationally sought-after speaker, Dr Howari regularly presents at national and international conferences and contributes to leading health industry publications. Living with type 1 diabetes for more than 34 years has provided her with a unique perspective that combines lived experience with over two decades of clinical practice. This dual perspective underpins her advocacy for integrated, multidisciplinary and technology-enabled healthcare. As a respected media commentator, she has been featured across print, radio, television, digital media and podcasts, providing expert commentary on diabetes, eye health and healthcare innovation. She is also a UTS Diabetes Educator Course Advisory Committee Member.

Dr. Nan Hee Kim is a Professor of Endocrinology at Korea University College of Medicine, Seoul, Korea. Her research focuses on diabetes and its complications, particularly diabetic kidney disease, with a strong interest in multi-omics approaches and precision medicine. She serves as a principal investigator of the Korean Genome and Epidemiology Study (KoGES), a large population-based cohort that has been followed for over 25 years. Her work integrates epidemiology and multimodal deep phenotyping to elucidate the mechanisms underlying diabetes and aging.

Mitsuru Ohsugi, MD Chief, Division of Diabetes; Director, Diabetes Information Center National Center for Global Health and Medicine / JIHS, Tokyo, Japan Dr. Ohsugi graduated from the University of Tokyo Faculty of Medicine and completed training and research at the U.S. Naval Hospital Yokosuka, the University of Hawaii, and the Division of Endocrinology, Diabetes & Lipid Research at Washington University in St. Louis. He subsequently served at the University of Tokyo Hospital before assuming his current positions. His clinical and research interests encompass diabetes, endocrine disorders, and obesity, including the development of novel therapies and public health communication. He leads J-DREAMS, a nationwide Japanese diabetes clinical database.

Professor Josephine Forbes from Mater Research-UQ in Queensland, is the current President of the Australian Diabetes Society advocating and supporting better and more equitable health care and research funding for people with diabetes. Her translational research extends from bench to bedside for novel therapies to prevent type 1 diabetes and kidney disease in vulnerable groups including youth and those who identify as Aboriginal and Torres Strait Islander Peoples.

Associate Professor Brendon Neuen is a Nephrologist, Director of Kidney Trials, Royal North Shore Hospital and Program Lead, Renal and Metabolic Division at The George Institute for Global Health. He completed training in nephrology and clinical trials in Sydney, Oxford, and Boston. He serves on the steering committees of multiple international trials evaluating new therapeutic strategies to reduce cardio-renal risk and co-chairs the SGLT2 Meta-Analysis Cardio-Renal Trialists' Consortium, pooling data from over 90,000 participants from large-scale randomized trials. His work has been cited more than 30 international guidelines and scientific statements.

Professor Elif Ekinci is a clinician scientist, an academic endocrinologist who is working to translate research into improved outcomes for people with type 1 and type 2 diabetes. Her research is focused on the pathophysiology, prevention, detection and treatment of diabetes and its complications in humans. She is the Head of Department of Medicine at the University of Melbourne and overseas the Department of Medicine activity across The University of Melbourne affiliated hospitals including Austin Health, Melbourne Health, Northern Health, Western Health and St Vincent's Health. She is also the Weary Dunlop Medical Research Foundation Professorial Fellow in Metabolic Medicine and Dame Kate Campbell Fellow at The University of Melbourne. The Dame Kate Campbell Fellowship is given to researchers recognising incredible contributions to the University of Melbourne for outstanding research and wider involvement in our local community and across the globe. She is also the Head of Diabetes research at Austin Health, where she heads diabetes and obesity clinical trials at the Centre for Research and Education in Diabetes and Obesity. Prof Ekinci is the inaugural director of Australian Centre for Accelerating Diabetes Innovations (ACADI). ACADI will deliver novel interventions for timely diagnosis, prevention and treatment of diabetes and its complications with the access to clinical evaluation, leadership and networks, research commercialisation experience and workforce training. ACADI's design responds to key barriers slowing Australian development of innovations.